Actively Recruiting
Evaluation of Different Diagnostic and Therapeutic Strategies in Patients with Thyroid Diseases An Observational Prospective and Retrospective Study
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-17
5850
Participants Needed
1
Research Sites
1043 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research investigates different diagnostic and treatment strategies for patients with various thyroid conditions, including hypothyroidism, hyperthyroidism or thyrotoxicosis, benign thyroid nodules, and thyroid carcinoma. It is an observational, single-center study that includes both retrospective and prospective phases, focusing on patients already followed by the Center with at least a 3-month follow-up. The study aims to gather detailed information about the patient population with thyroid diseases over a long period. The study does not involve any new treatments or procedures beyond standard clinical care. In the retrospective phase, patients diagnosed from January 1, 1995, until the study approval are included, while the prospective phase enrolls patients diagnosed from the study approval date onward for the next 10 years. Each patient will be followed for up to 20 years, with data collected from routine clinical visits and tests. Participants will undergo no additional procedures outside of their usual care. Researchers will collect clinical information typically gathered during regular medical visits, without extra laboratory or imaging tests. The main outcome is to characterize the patient population with thyroid diseases throughout the study period, which averages 17 years. The study focuses on long-term observation and monitoring of thyroid conditions under normal clinical practice.
CONDITIONS
Official Title
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age older than 18 years at the time of diagnosis
- Diagnosis of thyroid pathology (hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodule, or thyroid carcinoma) made at our Center or another Center from 01/01/1995 to study approval (retrospective phase) or from study approval to the next 10 years (prospective phase)
- Patient has provided informed consent
You will not qualify if you...
- Follow-up lasting less than 3 months
- Incomplete or missing clinical data that may affect proper patient assessment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
U
Uberto Pagotto, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here